Pediatric Clinical Drug Trials in Low-Income Countries: Key Ethical Issues
- 267 Downloads
Potential child participants in clinical research trials in low-income countries are often vulnerable because of poverty, high morbidity and mortality, inadequate education, and varied local cultural norms. However, vulnerability by itself must not be accepted as an obstacle blocking children from the health benefits that may accrue as an outcome of sound clinical research. As greater emphasis is placed on evidence-based treatment of children, it should be anticipated that there will be a growing call for agreement on principles to guide clinical investigations in low-income countries. There is now general acceptance of the view that children must be protected from non-evidence-based interventions and from substandard treatments. The questions remaining relate to how best to stimulate clinical research activity that will serve the needs of infants, children, and youth in developing countries and how best to assign priority to ethically sound research that will meet their clinical requirements. In low-income countries, 39 % of citizens are 13 years of age or younger, and consequently it is certain that clinical investigations of some new therapeutic products will be conducted there more frequently. This review offers some suggestions for approaches that will help to achieve more effective ethical consideration, including (1) improving the quality of research ethics boards; (2) fostering collaborative partnerships among important stakeholders; (3) making concerted efforts to build capacity; (4) improving the quality of the consent and waiver process; and (5) developing improved governance for harmonized ethics platforms. Continuing support by international organizations is required to sustain the establishment and maintenance of stronger research ethics boards to protect children enrolled in clinical trials. This review underscores the importance of developing a culture of solidarity and true partnership between developed and low-income country organizations, which will allow all those involved, and especially child patients, to benefit from the advancement of therapeutics.
KeywordsCapacity Building Research Ethic Board Trovafloxacin Clinical Trial Unit Collaborative Partnership
No funding was received in support of this review. Stuart M. MacLeod, David C. Knoppert, Michèle Stanton-Jean, and Denise Avard have no conflicts of interest.
- 1.Reynolds-Whyte S. Therapeutic research in low income countries: studying trial communities. Arch Dis Child (Online). 2014. doi: 10.1136/archdischild-2013-304852.
- 2.World Health Organization. International clinical trials registry platform. Clinical trials in children. 2014. http://apps.who.int/trialsearch/AdvSearch.aspx. Accessed 12 Nov 2014.
- 3.World Bank population statistics. http://data.worldbank.org/indicator/SP.POP.0014.TO.ZS. Accessed 21 Sept 2014.
- 4.World Health Organization. African Vaccine Regulatory Forum (AVAREF). http://www.who.int/immunization_standards/vaccine_regulation/africa_network/en/index.html. Accessed 21 Sept 2014.
- 5.Pan African Clinical Trials Registry (PACTR). http://www.pactr.org/. Accessed 21 Sept 2014.
- 6.European and Developing Countries Clinical Trials Partnership (EDCTP). http://www.edctp.org/. Accessed 21 Sept 2014.
- 7.Council of Canadian Academies. Improving medicines for children in Canada. Ottawa (ON): the expert panel on therapeutic products for infants, children, and youth, council of Canadian academies. 2014. http://www.scienceadvice.ca/uploads/eng/assessments%20and%20publications%20and%20news%20releases/therapeutics/therapeutics_fullreporten.pdf. Accessed 11 Nov 2014.
- 13.Centre of Genomics and Policy (CGP). Maternal Infant Child and Youth Research Network (MICYRN). Best practices for research involving children and adolescents: Genetic, Pharmaceutical and Longitudinal Studies. 2012. http://www.genomicsandpolicy.org/en/best-practices-2012. Accessed 11 Nov 2014.
- 14.Nuffield Council on Bioethics. The ethics of research related to healthcare in developing countries. 2005. http://www.nuffieldbioethics.org/project/research-developing-countries. Accessed 21 Sept 2014.
- 15.Graham A, Powell M, Taylor N, Anderson D, Fitzgerald R. Ethical research involving children. Florence: UNICEF Office of Research-Innocenti; 2013.Google Scholar
- 18.Canadian Council on Learning. Health literacy in Canada: initial results from the International adult literacy and skills survey. Ottawa. 2007. p. 17–21. http://www.ccl-cca.ca/pdfs/HealthLiteracy/HealthLiteracyinCanada.pdf. Accessed 11 Nov 2014.
- 22.World Medical Association. Declaration of Helsinki, 2013. http://www.wma.net/en/20activities/10ethics/10helsinki/. Accessed 21 Sept 2014.
- 23.Strategic Initiative for Developing Capacity in Ethical Review SIDCER. Strategic Plan, UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases Collaborative Project. 2003. p 11. http://www.who.int/sidcer/about/strategic_plan/en/strategic_plan_082003.pdf. Accessed 12 Nov 2014.
- 24.Cox S, Ross K, Townsend A, Avard D, Woodgate R. From stakeholders to shareholders: engaging consumers in health research. Health Law Rev. 2011;19:63–71.Google Scholar
- 25.Molyneux S, Njue M, Boga M, Akello L, Olupot-Olupot P, Engoru C, et al. ‘The words will pass with the blowing wind’: staff and parent views of the deferred consent process, with prior assent, used in an emergency fluids trial in two African hospitals. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054894 Accessed 21 Sept 2014.
- 26.UNESCO. Universal Declaration on Bioethics and Human Rights. 2005. http://unesdoc.unesco.org/images/0014/001461/146180e.pdf. Accessed 21 Sept 2014.
- 27.United Nations Educational, Scientific and Cultural Organization. 1993–2013: Twenty years of bioethics at UNESCO. http://www.unesco.org/new/en/social-and-human-sciences/themes/global-ethics-observatory/. Accessed 12 Nov 2014.
- 31.Victoria Newborn Screening Review Committee Final Report. 2006. https://www.privacy.vic.gov.au/privacy/web2.nsf/files/victorian-newborn-screening-review-committee-final-report. Accessed 21 Sept 2014.
- 33.Tri-Council Policy Statement 2—Chapter 9, research involving the First Nations, Inuit and Metis Peoples of Canada. http://www.pre.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/chapter9-chapitre9/. Accessed 21 Sept 2014.
- 34.Cahill LS. Bioethics and the Common Good. Milwaukee: Marquette University Press; 2004.Google Scholar
- 37.Murray LK, Dorsey S, Skavenski S, Kasoma M, Imasiku M, Bolton P, et al. Identification, modification, and implementation of an evidence-based psychotherapy for child in low-income country: the use of TF-CBT in Zambia. Int J Ment Health Syst. doi: 10.1186/1752-4458-7-24.